Cargando…

Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI

During the last decades, the utilization of imaging modalities such as single photon emission computed tomography (SPECT), positron emission tomography (PET), and magnetic resonance imaging (MRI) in every day clinical practice has enabled clinicians to diagnose diseases accurately at early stages. R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karageorgou, Maria-Argyro, Bouziotis, Penelope, Stiliaris, Efstathios, Stamopoulos, Dimosthenis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919131/ https://www.ncbi.nlm.nih.gov/pubmed/36770463 http://dx.doi.org/10.3390/nano13030503

Ejemplares similares

Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2021)

(99m)Tc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2022)

A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis
por: Tsoukalas, Charalampos, et al.
Publicado: (2018)

Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2017)

Radiolabelling of Extracellular Vesicles for PET and SPECT imaging
por: Khan, Azalea A., et al.
Publicado: (2021)

Radiolabeled PET/MRI Nanoparticles for Tumor Imaging
por: Forte, Ernesto, et al.
Publicado: (2019)

Potential clinical applications of bimodal PET-MRI or SPECT-MRI agents†
por: de Rosales, Rafael T M
Publicado: (2014)

Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging
por: Tsoukalas, Charalmpos, et al.
Publicado: (2015)

Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents
por: Kanagasundaram, Thines, et al.
Publicado: (2021)

Development of (153)Sm-DTPA-SPION as a theranostic dual contrast agents in SPECT/MRI
por: Gholami, Amir, et al.
Publicado: (2016)

Bisphosphonate-Anchored PEGylation and Radiolabeling of Superparamagnetic Iron Oxide: Long-Circulating Nanoparticles for in Vivo Multimodal (T1 MRI-SPECT) Imaging
por: Sandiford, Lydia, et al.
Publicado: (2012)

Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with (68)Ga and (177)Lu as Potential Theranostic Agents
por: Salvanou, Evangelia-Alexandra, et al.
Publicado: (2022)

Phenotyping of Macrophages After Radiolabeling and Safety of Intra-arterial Transplantation Assessed by SPECT/CT and MRI
por: Friberger, Ida, et al.
Publicado: (2023)

T(1)–T(2) Dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes
por: Szpak, Agnieszka, et al.
Publicado: (2014)

Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
por: Hicks, Justin W., et al.
Publicado: (2010)

Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging
por: Gawne, Peter J., et al.
Publicado: (2022)

Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas
por: Bertagna, Francesco, et al.
Publicado: (2020)

Lymph node imaging using novel simultaneous PET/MRI and dual-modality imaging agent
por: Ko, Guen Bae, et al.
Publicado: (2015)

Biodistribution of (68/67)Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging
por: Díez-Villares, Sandra, et al.
Publicado: (2021)

Fe/Mn Multilayer Nanowires as High-Performance T(1)-T(2) Dual Modal MRI Contrast Agents
por: Cao, Xiaoming, et al.
Publicado: (2021)

A pH-responsive T(1)-T(2) dual-modal MRI contrast agent for cancer imaging
por: Lu, Hongwei, et al.
Publicado: (2022)

Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with (225)Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer
por: Cędrowska, Edyta, et al.
Publicado: (2020)

Reporter Genes for Brain Imaging Using MRI, SPECT and PET
por: Gao, Tianxin, et al.
Publicado: (2022)

New imaging agents targeting chemokine receptor CXCR4 for PET/SPECT and MRI
por: Poty, Sophie, et al.
Publicado: (2014)

Chelator-Free/Chelator-Mediated Radiolabeling of Colloidally Stabilized Iron Oxide Nanoparticles for Biomedical Imaging
por: Papadopoulou, Sofia, et al.
Publicado: (2021)

Synthesis of (64)Cu(II)–Bis(dithiocarbamatebisphosphonate) and Its Conjugation with Superparamagnetic Iron Oxide Nanoparticles: In Vivo Evaluation as Dual-Modality PET–MRI Agent**
por: Torres Martin de Rosales, Rafael, et al.
Publicado: (2011)

Iron Oxide as an MRI Contrast Agent for Cell Tracking
por: Korchinski, Daniel J., et al.
Publicado: (2015)

Aluminium hydroxide stabilised MnFe(2)O(4) and Fe(3)O(4) nanoparticles as dual-modality contrasts agent for MRI and PET imaging
por: Cui, Xianjin, et al.
Publicado: (2014)

Radiolabeled methotrexate as a diagnostic agent of inflammatory target sites: A proof-of-concept study
por: Papachristou, Maria, et al.
Publicado: (2018)

ES-MION-Based Dual-Modality PET/MRI Probes for Acidic Tumor Microenvironment Imaging
por: Wei, Xiuyan, et al.
Publicado: (2022)

Innovative multimodal DOTA/NODA nanoparticles for MRI and PET imaging for tumor detection
por: Truillet, Charles, et al.
Publicado: (2014)

Magnetism and superconductivity in low-dimensional systems: utilization in future applications
por: Stamopoulos, Dimosthenis, et al.
Publicado: (2008)

Methods for Radiolabelling Nanoparticles: SPECT Use (Part 1)
por: Varani, Michela, et al.
Publicado: (2022)

Targeted Dual-Modal PET/SPECT-NIR Imaging: From Building Blocks and Construction Strategies to Applications
por: Usama, Syed Muhammad, et al.
Publicado: (2022)

Biodistribution of Mesoporous Carbon Nanoparticles via Technetium-99m Radiolabelling after Oral Administration to Mice
por: Mamai, Maria, et al.
Publicado: (2021)

Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles
por: Pham, TH Nguyen, et al.
Publicado: (2017)

Development of clinical simultaneous SPECT/MRI
por: Hutton, Brian F, et al.
Publicado: (2018)

PET/MR and SPECT/MR multimodal imaging constructs: Direct radiolabelling of silica shell iron oxide nanorods for use in liver imaging and potential for hyperthermia therapy
por: Bignell, Haylay
Publicado: (2015)

Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging
por: Mitchell, Nick, et al.
Publicado: (2013)

Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging
por: Chrastina, Adrian, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_88lovjjludnl7usd59p3ckt67o